Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Sweed Launches the Cannabis Industry’s First “Bug Bounty” Program to Test Customer Data Security Against Hackers
-
HARD MTN DEW LAUNCHES FIRST-EVER DRINKABLE HOLIDAY CARDS
-
Cloudastructure Secures Six-Figure Contract to Modernize Multifamily Security Operations
-
Sun Cruiser Taps Basketball Star Sophie Cunningham as First Athlete Partner
-
Eleven Sichenzia Ross Ference Carmel LLP Attorneys Selected for Inclusion on 2025 Super Lawyers and Rising Stars Lists
-
Glasswing Ventures Raises Oversubscribed $200M Fund III to Accelerate AI-native and Frontier Technology Adoption in the Enterprise
-
JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025
-
Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics
-
AIM ImmunoTech Details New UPMC Abstract on Completed Clinical Trial Involving Ampligen’s Synergistic Potential in the Treatment of Advanced Recurrent Ovarian Cancer
-
Tech CEO Dan Herbatschek Announces Ramsey Theory Group to Attend Web Summit 2025 This Week in Lisbon as AI Spending Enters Unprecedented Growth Phase
-
Propanc Biopharma, Inc. Secures up to $100 Million Private Placement to Support Digital Asset Acquisition Strategy & Accelerate Company’s R&D Pipeline
-
Propanc Biopharma, Inc. Secures up to $100 Million Private Placement to Support Digital Asset Acquisition Strategy & Accelerate Company’s R&D Pipeline
-
Callan JMB Expands Logistics Platform Into Food Sampling Sector, Advancing Multi-Variant Growth Strategy
-
Form 8.3 - Avadel Pharmaceuticals plc
-
AI Brokers, The World First Chat Based Stock Investment Brokers, Launches Alpha Version for Early Testers
-
Oil & Gas Virtual Investor Conference Agenda Announced for November 13th
-
Fusemachines Welcomes Genese Solution as an Authorized Reseller
-
Oil & Gas Virtual Investor Conference Agenda Announced for November 13th
-
Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials
-
Transactions in connection with share buyback programme
-
Fusemachines Welcomes Genese Solution as an Authorized Reseller
-
Form 8.3 - Unite Group Plc
-
WORKSPORT ANNOUNCES FINAL PRICING AND INITIAL MODEL LINEUP FOR SOLIS SOLAR TONNEAU COVER
-
Form 8.3 - Idox Plc
-
American Rare Earths Announces Strong Initial Beneficiation Optimization Results and Updated Preliminary Mineral Processing Flowsheet
-
BioCardia Announces Henry Ford Health Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial
-
Vittoria Biotherapeutics Announces Presentation of First-in-Human Interim Phase1 Data for VIPER-101 at ASH2025
-
Genius Group and Nuanu Complete Agreements, With a Combined Valuation of $14 Million, to Launch Genius School and Genius City, Bali
-
Azurity Pharmaceuticals Names Ogilvy Health as PR and Marketing Agency of Record to Drive Strategic Brand Repositioning and Enhance Market Visibility
-
Streamex Corp. (NASDAQ: STEX) Announces Launch of $100,000,000 USD GLDY Pre-Sale – A Gold-Backed Yield Generating Stablecoin Offering Institutional Yield on Physical Gold Bullion
-
HyOrc (HYOR) Enters North American Rail with Hydrogen-Ready Engine MOU; Green Methanol Project Advances Toward Financed Offtake, Signaling Clear Path to Revenue
-
Houston American Energy Corp. Reports Preliminary, Unaudited Results for Third Quarter 2025
-
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
-
Currenc Group Inc. Announces Third Quarter 2025 Unaudited Financial Results
-
WISeKey International Holding AG (Nasdaq: WKEY) and Columbus Acquisition Corp. (Nasdaq: COLA) Execute Business Combination Agreement to Publicly List WISeKey’s Subsidiary WISeSat.Space Corp. Under T
-
Woodward Schedules Fiscal 2025 Fourth Quarter and Full Year Earnings Release and Conference Call
-
NewGen Announces Up to US$2 Million Share Repurchase Program
-
GIFTIFY, INC. REPORTS THIRD QUARTER 2025 RESULTS
-
The Energy Breakthrough That Could Power the AI Era
-
The New Gold Rush of the AI Era
-
Vatica Health earns consistent high performer award
-
PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025
-
Akari Therapeutics Presents Promising Immuno-Oncology Data for its Novel Splicing-Targeted ADC Payload Driving Immune Activation, Both as Single Agent and in Combination with Anti-PD1 Checkpoint Inhib
-
Roper Technologies strengthens AI leadership with key executive appointments
-
Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs
-
Rubicon Organics Secures $4 million in Financing to Support Strategic Growth Initiatives
-
HeartCore Granted 180-Day Extension to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
-
GlobalFoundries Licenses GaN Technology from TSMC to Accelerate U.S.-Manufactured Power Portfolio for Datacenter, Industrial and Automotive Customers
-
VisionWave Unveils the Varan UGV — Leading the Ground Autonomy Revolution
-
FAST TRACK GROUP Completes Three-Part Brand Activation Project
